| Dr Kenneth Reed Gravett, DO | |
|
517 Washington St, Shelbyville, KY 40065-1129 | |
| (502) 633-0120 | |
| (502) 633-0882 |
| Full Name | Dr Kenneth Reed Gravett |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 44 Years |
| Location | 517 Washington St, Shelbyville, Kentucky |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548261191 | NPI | - | NPPES |
| 64020787 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02078 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Reed Gravett, DO 517 Washington St, Shelbyville, KY 40065-1129 Ph: (502) 633-0120 | Dr Kenneth Reed Gravett, DO 517 Washington St, Shelbyville, KY 40065-1129 Ph: (502) 633-0120 |
News Archive
Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.
Female rats that inhaled vaporized cannabis daily for a month developed a blunted physiological response to stress, according to a new study by Washington State University researchers.
An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes the disease. There is no licensed treatment for Marburg infection, which has a high fatality rate.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
› Verified 2 days ago
Dr. Ron E Creque Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Stonecrest Road, Suite 3, Shelbyville, KY 40065 Phone: 502-633-5565 Fax: 502-633-5154 | |
Dr. Ronald E Waldridge Sr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 60 Mack Walters Rd, Shelbyville, KY 40065 Phone: 502-633-4622 Fax: 502-633-6925 | |
David W Wallace, MD MBA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Hospital Dr, Suite 1, Shelbyville, KY 40065 Phone: 502-633-3525 Fax: 502-633-8075 | |
Leticia Kathryn Allen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 60 Mack Walters Rd, Shelbyville, KY 40065 Phone: 502-633-4622 Fax: 502-633-6925 | |
Dr. William J Jackson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 148 Midland Blvd, Shelbyville, KY 40065 Phone: 502-647-1958 Fax: 502-647-1940 | |
James R Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Hospital Dr, Ste 1, Shelbyville, KY 40065 Phone: 502-633-3525 Fax: 502-633-8075 | |
Dr. Jena Thomas Ruxer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4000 |